Sabari recommends regular activity, such as walking 30 minutes a day several times a week, to help maintain lung strength.
University of Queensland researchers who mapped cancer cell "neighborhoods" in the most common type of lung cancer have found ...
MedPage Today on MSN
Time of Day Matters for Immunochemotherapy in Lung Cancer
This is a "landmark study" for cancer immunotherapy and circadian medicine, researcher say ...
SurvivorNet on MSN
More control, better quality of life: What to know about tarlatamab, the new immunotherapy drug approved for small-cell lung cancer
Tarlatamab (Imdelltra) is a new type of immunotherapy approved for people with small-cell lung cancer whose disease has ...
Sabari — editor-in-chief of CURE, assistant professor at NYU Grossman School of Medicine, and director of High Reliability Organization Initiatives at Perlmutter Cancer Center — discussed how various ...
Lung cancer tumor cells in mice communicate with the brain, sending signals to deactivate the body’s immune response, a study ...
Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of treatments to fire up their immune systems. The only difference was that ...
Patients with advanced lung cancer who received immunochemotherapy before 15:00 (3 p.m.) had a more delayed disease ...
SurvivorNet on MSN
Could timing give your cancer treatment a boost? New study on the best time to receive immunotherapy & chemo for non-small cell lung cancer
A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with NSCLC live longer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results